|
1
|
McGarrity TJ and Amos C: Peutz-Jeghers
syndrome: Clinicopathology and molecular alterations. Cell Mol Life
Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rustgi AK: The genetics of hereditary
colon cancer. Genes Dev. 21:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hemminki A, Markie D, Tomlinson I,
Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M,
Höglund P, et al: A serine/threonine kinase gene defective in
Peutz-Jeghers syndrome. Nature. 391:184–187. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hearle N, Schumacher V, Menko FH,
Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott
RJ, Lim W, et al: Frequency and spectrum of cancers in the
Peutz-Jeghers syndrome. Clin Cancer Res. 12:3209–3215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ji H, Ramsey MR, Hayes DN, Fan C, Mcnamara
K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, et al:
LKB1 modulates lung cancer differentiation and metastasis. Nature.
448:807–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou J, Huang W, Tao R, Ibaragi S, Lan F,
Ido Y, Wu X, Alekseyev YO, Lenburg ME, Hu GF, et al: Inactivation
of AMPK alters gene expression and promotes growth of prostate
cancer cells. Oncogene 2. 8:1993–2002. 2009. View Article : Google Scholar
|
|
7
|
Fenton H, Carlile B, Montgomery EA,
Carraway H, Herman J, Sahin F, Su GH and Argani P: LKB1 protein
expression in human breast cancer. Appl Immunohistochem Mol
Morphol. 14:146–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanchez-Cespedes M: A role for LKB1 gene
in human cancer beyond the Peutz-Jeghers syndrome. Oncogene.
26:7825–7832. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ylikorkala A, Rossi DJ, Korsisaari N,
Luukko K, Alitalo K, Henkemeyer M and Mäkelä TP: Vascular
abnormalities and deregulation of VEGF in Lkb1-deficient mice.
Science. 293:1323–1326. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jishage K, Nezu J, Kawase Y, Iwata T,
Watanabe M, Miyoshi A, Ose A, Habu K, Kake T, Kamada N, et al: Role
of Lkb1, the causative gene of Peutz-Jegher's syndrome, in
embryogenesis and polyposis. Proc Natl Acad Sci USA. 99:8903–8908.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Williams T and Brenman JE: LKB1 and AMPK
in cell polarity and division. Trends Cell Biol. 18:193–198. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: Metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Partanen JI, Tervonen TA, Myllynen M, Lind
E, Imai M, Katajisto P, Dijkgraaf GJ, Kovanen PE, Mäkelä TP, Werb
Z, et al: Tumor suppressor function of Liver kinase B1 (Lkb1) is
linked to regulation of epithelial integrity. Proc Natl Acad Sci
USA. 109:E388–E397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yeh HJ, Chu TH and Shen TW: Ultrastructure
of continuously cultured adult human liver cells. Acta Biol Exp
Sinica. 14:361–365. 1980.
|
|
15
|
Li CY, Cao CZ, Xu WX, Cao MM, Yang F, Dong
L, Yu M, Zhan YQ, Gao YB, Li W, et al: Recombinant human hepassocin
stimulates proliferation of hepatocytes in vivo and improves
survival in rats with fulminant hepatic failure. Gut. 59:817–826.
2010. View Article : Google Scholar
|
|
16
|
Tao YM, Huang JL, Zeng S, Zhang S, Fan XG,
Wang ZM, Yang HX, Yuan XH, Wang P, Wu F, et al: BTB/POZ
domain-containing protein 7: Epithelial-mesenchymal transition
promoter and prognostic biomarker of hepatocellular carcinoma.
Hepatology. 57:2326–2337. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wan X, Xu C, Lin Y, Lu C, Li D, Sang J, He
H, Liu X, Li Y and Yu C: Uric acid regulates hepatic steatosis and
insulin resistance through the NLRP3 inflammasome-dependent
mechanism. J Hepatol. 64:925–932. 2016. View Article : Google Scholar
|
|
18
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao
Y, Li Y, Zeng T, Hu J, Zhang L, et al: HBx-mediated miR-21
upregulation represses tumor-suppressor function of PDCD4 in
hepatocellular carcinoma. Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang X, Wang P, Gao Q and Tao X:
Exogenous activation of LKB1/AMPK signaling induces G1
arrest in cells with endogenous LKB1 expression. Mol Med Rep.
9:1019–1024. 2014.PubMed/NCBI
|
|
20
|
Liang X, Wang P, Gao Q, Xiang T and Tao X:
Endogenous LKB1 knockdown accelerates G1/S transition
through p53 and p16 pathways. Cancer Biol Ther. 9:156–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tiainen M, Ylikorkala A and Mäkelä TP:
Growth suppression by Lkb1 is mediated by a G1 cell
cycle arrest. Proc Natl Acad Sci USA. 96:9248–9251. 1999.
View Article : Google Scholar
|
|
22
|
Lee SM, Choi JE, Na YK, Lee EJ, Lee WK,
Choi YY, Yoon GS, Jeon HS, Kim DS and Park JY: Genetic and
epigenetic alterations of the LKB1 gene and their associations with
mutations in TP53 and EGFR pathway genes in Korean non-small cell
lung cancers. Lung Cancer. 81:194–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tiainen M, Vaahtomeri K, Ylikorkala A and
Mäkelä TP: Growth arrest by the LKB1 tumor suppressor: Induction of
p21WAF1/CIP1. Hum Mol Genet. 11:1497–1504. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gopinath P and Ghosh SS: Apoptotic
induction with bifunctional E. coli cytosine deaminase-uracil
phosphoribosyltransferase mediated suicide gene therapy is
synergized by curcumin treatment in vitro. Mol Biotechnol.
39:39–48. 2008. View Article : Google Scholar
|
|
25
|
Giacinti C and Giordano A: RB and cell
cycle progression. Oncogene. 25:5220–5227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee CJ, Jang JH, Lee JY, Lee MH, Li Y, Ryu
HW, Choi KI, Dong Z, Lee HS, Oh SR, et al: Aschantin targeting on
the kinase domain of mammalian target of rapamycin suppresses
epidermal growth factor-induced neoplastic cell transformation.
Carcinogenesis. 36:1223–1234. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
George SH, Milea A, Sowamber R, Chehade R,
Tone A and Shaw PA: Loss of LKB1 and p53 synergizes to alter
fallopian tube epithelial phenotype and high-grade serous
tumorigenesis. Oncogene. 35:59–68. 2016. View Article : Google Scholar
|
|
28
|
Okon IS, Coughlan KA, Zhang C, Moriasi C,
Ding Y, Song P, Zhang W, Li G and Zou MH: Protein kinase LKB1
promotes RAB7-mediated neuropilin-1 degradation to inhibit
angiogenesis. J Clin Invest. 124:4590–4602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao Y, Zhang W, Han X, Li F, Wang X, Wang
R, Fang Z, Tong X, Yao S, Li F, et al: YAP inhibits squamous
transdifferentiation of Lkb1-deficient lung adenocarcinoma through
ZEB2-dependent DNp63 repression. Nat Commun. 5:46292014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tanwar PS, Mohapatra G, Chiang S, Engler
DA, Zhang L, Kaneko-Tarui T, Ohguchi Y, Birrer MJ and Teixeira JM:
Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface
epithelium induces papillary serous ovarian cancer. Carcinogenesis.
35:546–553. 2014. View Article : Google Scholar :
|
|
31
|
Kavsan VM, Iershov AV and Balynska OV:
Immortalized cells and one oncogene in malignant transformation:
Old insights on new explanation. BMC Cell Biol. 12:232011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sebbagh M, Olschwang S, Santoni M-J and
Borg J-P: The LKB1 complex-AMPK pathway: The tree that hides the
forest. Fam Cancer. 10:415–424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alessi DR, Sakamoto K and Bayascas JR:
LKB1-dependent signaling pathways. Annu Rev Biochem. 75:137–163.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pineau P, Marchio A, Nagamori S, Seki S,
Tiollais P and Dejean A: Homozygous deletion scanning in
hepatobiliary tumor cell lines reveals alternative pathways for
liver carcinogenesis. Hepatology. 37:852–861. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Berger AH, Knudson AG and Pandolfi PP: A
continuum model for tumour suppression. Nature. 476:163–169. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qiu W, Schönleben F, Thaker HM, Goggins M
and Su GH: A novel mutation of STK11/LKB1 gene leads to the loss of
cell growth inhibition in head and neck squamous cell carcinoma.
Oncogene. 25:2937–2942. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gomaa AI, Khan SA, Toledano MB, Waked I
and Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology,
risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nakau M, Miyoshi H, Seldin MF, Imamura M,
Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of
heterozygosity in Lkb1 gene knockout mice. Cancer Res.
62:4549–4553. 2002.PubMed/NCBI
|
|
39
|
Jain D: Tissue diagnosis of hepatocellular
carcinoma. J Clin Exp Hepatol. 4(Suppl 3): S67–S73. 2014.
View Article : Google Scholar
|
